25 XP   0   0   10

Zhejiang Hisoar Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Hisoar together

PenkeI guess you are interested in Zhejiang Hisoar Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Hisoar Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Hisoar Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisoar Pharmaceutical Co Ltd.

Quick analysis of Hisoar (30 sec.)










What can you expect buying and holding a share of Hisoar? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.42
Expected worth in 1 year
¥3.04
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
¥-0.30
Return On Investment
-4.7%

For what price can you sell your share?

Current Price per Share
¥6.44
Expected price per share
¥3.91 - ¥6.6498
How sure are you?
50%

1. Valuation of Hisoar (5 min.)




Live pricePrice per Share (EOD)

¥6.44

Intrinsic Value Per Share

¥-0.43 - ¥2.24

Total Value Per Share

¥2.99 - ¥5.66

2. Growth of Hisoar (5 min.)




Is Hisoar growing?

Current yearPrevious yearGrowGrow %
How rich?$764.5m$850.2m-$50.4m-6.3%

How much money is Hisoar making?

Current yearPrevious yearGrowGrow %
Making money-$14.8m$1.4m-$16.3m-110.0%
Net Profit Margin-21.7%1.6%--

How much money comes from the company's main activities?

3. Financial Health of Hisoar (5 min.)




What can you expect buying and holding a share of Hisoar? (5 min.)

Welcome investor! Hisoar's management wants to use your money to grow the business. In return you get a share of Hisoar.

What can you expect buying and holding a share of Hisoar?

First you should know what it really means to hold a share of Hisoar. And how you can make/lose money.

Speculation

The Price per Share of Hisoar is ¥6.44. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hisoar.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hisoar, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.42. Based on the TTM, the Book Value Change Per Share is ¥-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hisoar.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%-0.01-0.1%0.000.0%0.000.1%0.010.1%
Usd Book Value Change Per Share-0.01-0.1%-0.01-0.2%0.000.0%0.000.0%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.00-0.1%-0.01-0.2%0.000.0%0.010.1%0.020.3%
Usd Price Per Share0.77-1.04-0.96-1.03-1.21-
Price to Earnings Ratio69.53--37.49-27.67-73.29-253.00-
Price-to-Total Gains Ratio-164.72--376.74-99.11-14.05-85.15-
Price to Book Ratio1.64-2.09-1.83-2.06-3.96-
Price-to-Total Gains Ratio-164.72--376.74-99.11-14.05-85.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.889364
Number of shares1124
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.01
Gains per Quarter (1124 shares)-11.708.41
Gains per Year (1124 shares)-46.8133.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
112-59-5726824
223-117-104511658
335-176-151772492
447-234-19810232126
559-293-24512841160
670-351-29215349194
782-410-33917957228
894-468-38620465262
9105-527-43323073296
10117-585-48025581330

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%8.04.00.066.7%15.05.00.075.0%34.05.01.085.0%59.05.07.083.1%
Book Value Change Per Share0.04.00.00.0%6.06.00.050.0%13.07.00.065.0%28.012.00.070.0%48.023.00.067.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%63.00.08.088.7%
Total Gains per Share0.04.00.00.0%7.05.00.058.3%15.05.00.075.0%33.07.00.082.5%60.011.00.084.5%

Fundamentals of Hisoar

About Zhejiang Hisoar Pharmaceutical Co Ltd

Zhejiang Hisoar Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers antibiotics, cardiovascular products, hypoglycemic products, fine chemicals, dyes, intermediates, and other products, as well as clindamycin products. It also provides pharmaceutical, dyestuff, and other related services. The company was founded in 1966 and is based in Taizhou, China.

Fundamental data was last updated by Penke on 2024-05-05 22:39:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hisoar earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.2% means that ¥0.06 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 6.2%. The company is making a profit. +1
  • The TTM is -21.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ6.2%TTM-21.7%+27.9%
TTM-21.7%YOY1.6%-23.4%
TTM-21.7%5Y3.5%-25.2%
5Y3.5%10Y10.0%-6.5%
1.1.2. Return on Assets

Shows how efficient Hisoar is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.4% Return on Assets means that Hisoar generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.4%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -1.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.4%TTM-1.4%+1.8%
TTM-1.4%YOY0.1%-1.5%
TTM-1.4%5Y0.5%-1.9%
5Y0.5%10Y1.2%-0.7%
1.1.3. Return on Equity

Shows how efficient Hisoar is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Equity means Hisoar generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -1.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.6%TTM-1.9%+2.5%
TTM-1.9%YOY0.2%-2.1%
TTM-1.9%5Y0.6%-2.5%
5Y0.6%10Y1.6%-0.9%

1.2. Operating Efficiency of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hisoar is operating .

  • Measures how much profit Hisoar makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2.3%+2.3%
TTM-2.3%YOY1.5%-3.8%
TTM-2.3%5Y9.3%-11.6%
5Y9.3%10Y7.3%+2.1%
1.2.2. Operating Ratio

Measures how efficient Hisoar is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are ¥1.56 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 1.556. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.900. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.556TTM1.900-0.344
TTM1.900YOY1.736+0.164
TTM1.9005Y1.573+0.327
5Y1.57310Y1.127+0.445

1.3. Liquidity of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hisoar is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.49 means the company has ¥1.49 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 1.485. The company is just able to pay all its short-term debts.
  • The TTM is 1.481. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.485TTM1.481+0.004
TTM1.481YOY1.596-0.115
TTM1.4815Y2.217-0.737
5Y2.21710Y1.343+0.875
1.3.2. Quick Ratio

Measures if Hisoar is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.25 means the company can pay off ¥0.25 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.252. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.229. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.252TTM0.229+0.023
TTM0.229YOY0.285-0.056
TTM0.2295Y0.372-0.143
5Y0.37210Y0.387-0.015

1.4. Solvency of Zhejiang Hisoar Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hisoar assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hisoar to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that Hisoar assets are financed with 27.6% credit (debt) and the remaining percentage (100% - 27.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.276. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.283. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.276TTM0.283-0.007
TTM0.283YOY0.286-0.003
TTM0.2835Y0.228+0.055
5Y0.22810Y0.268-0.040
1.4.2. Debt to Equity Ratio

Measures if Hisoar is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 38.1% means that company has ¥0.38 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The MRQ is 0.381. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.396. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.381TTM0.396-0.014
TTM0.396YOY0.401-0.006
TTM0.3965Y0.302+0.093
5Y0.30210Y0.430-0.128

2. Market Valuation of Zhejiang Hisoar Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hisoar generates.

  • Above 15 is considered overpriced but always compare Hisoar to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 69.53 means the investor is paying ¥69.53 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The EOD is 79.959. Based on the earnings, the company is expensive. -2
  • The MRQ is 69.530. Based on the earnings, the company is expensive. -2
  • The TTM is -37.488. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD79.959MRQ69.530+10.429
MRQ69.530TTM-37.488+107.018
TTM-37.488YOY27.667-65.155
TTM-37.4885Y73.291-110.779
5Y73.29110Y253.004-179.712
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The EOD is 537.054. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 467.004. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 22.681. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD537.054MRQ467.004+70.051
MRQ467.004TTM22.681+444.323
TTM22.681YOY415.244-392.564
TTM22.6815Y164.047-141.366
5Y164.04710Y111.738+52.309
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hisoar is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Hisoar Pharmaceutical Co Ltd:

  • The EOD is 1.883. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.637. Based on the equity, the company is underpriced. +1
  • The TTM is 2.086. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.883MRQ1.637+0.246
MRQ1.637TTM2.086-0.448
TTM2.086YOY1.827+0.259
TTM2.0865Y2.060+0.026
5Y2.06010Y3.957-1.897
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Hisoar Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.040-0.094+134%-0.011-72%0.013-409%0.076-153%
Book Value Per Share--3.4203.578-4%3.803-10%3.624-6%3.079+11%
Current Ratio--1.4851.481+0%1.596-7%2.217-33%1.343+11%
Debt To Asset Ratio--0.2760.283-2%0.286-3%0.228+21%0.268+3%
Debt To Equity Ratio--0.3810.396-4%0.401-5%0.302+26%0.430-11%
Dividend Per Share--0.0060.019-66%0.030-79%0.041-85%0.048-87%
Eps--0.020-0.066+429%0.019+8%0.024-14%0.045-55%
Free Cash Flow Per Share--0.003-0.005+272%0.004-31%0.023-87%0.051-94%
Free Cash Flow To Equity Per Share--0.003-0.027+999%0.140-98%0.023-87%0.105-97%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--2.238--------
Intrinsic Value_10Y_min---0.434--------
Intrinsic Value_1Y_max--0.207--------
Intrinsic Value_1Y_min---0.027--------
Intrinsic Value_3Y_max--0.634--------
Intrinsic Value_3Y_min---0.095--------
Intrinsic Value_5Y_max--1.078--------
Intrinsic Value_5Y_min---0.180--------
Market Cap10424556800.000+13%9064832000.00012132306400.000-25%11246057200.000-19%12080507360.000-25%14126135596.000-36%
Net Profit Margin--0.062-0.217+452%0.016+282%0.035+78%0.100-38%
Operating Margin----0.0230%0.015-100%0.093-100%0.073-100%
Operating Ratio--1.5561.900-18%1.736-10%1.573-1%1.127+38%
Pb Ratio1.883+13%1.6372.086-21%1.827-10%2.060-21%3.957-59%
Pe Ratio79.959+13%69.530-37.488+154%27.667+151%73.291-5%253.004-73%
Price Per Share6.440+13%5.6007.495-25%6.948-19%7.463-25%8.727-36%
Price To Free Cash Flow Ratio537.054+13%467.00422.681+1959%415.244+12%164.047+185%111.738+318%
Price To Total Gains Ratio-189.433-15%-164.725-376.738+129%99.110-266%14.051-1272%85.149-293%
Quick Ratio--0.2520.229+10%0.285-12%0.372-32%0.387-35%
Return On Assets--0.004-0.014+428%0.001+268%0.005-20%0.012-64%
Return On Equity--0.006-0.019+421%0.002+247%0.006-4%0.016-62%
Total Gains Per Share---0.034-0.075+122%0.019-277%0.054-163%0.124-127%
Usd Book Value--764582751.137799771486.325-4%850213555.425-10%810121158.071-6%688250193.923+11%
Usd Book Value Change Per Share---0.006-0.013+134%-0.002-72%0.002-409%0.010-153%
Usd Book Value Per Share--0.4720.494-4%0.525-10%0.500-6%0.425+11%
Usd Dividend Per Share--0.0010.003-66%0.004-79%0.006-85%0.007-87%
Usd Eps--0.003-0.009+429%0.003+8%0.003-14%0.006-55%
Usd Free Cash Flow--670151.754-1151833.530+272%974272.086-31%5100581.134-87%11363630.001-94%
Usd Free Cash Flow Per Share--0.000-0.001+272%0.001-31%0.003-87%0.007-94%
Usd Free Cash Flow To Equity Per Share--0.000-0.004+999%0.019-98%0.003-87%0.014-97%
Usd Market Cap1439631294.080+13%1251853299.2001675471513.840-25%1553080499.320-19%1668318066.416-25%1950819325.808-36%
Usd Price Per Share0.889+13%0.7731.035-25%0.959-19%1.031-25%1.205-36%
Usd Profit--4501140.055-14830713.180+429%1487734.917+203%4721594.452-5%9785905.875-54%
Usd Revenue--72980863.29771339108.537+2%87474761.757-17%86106860.420-15%83845488.127-13%
Usd Total Gains Per Share---0.005-0.010+122%0.003-277%0.007-163%0.017-127%
 EOD+3 -5MRQTTM+24 -10YOY+11 -245Y+5 -3010Y+9 -27

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Hisoar Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1579.959
Price to Book Ratio (EOD)Between0-11.883
Net Profit Margin (MRQ)Greater than00.062
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.252
Current Ratio (MRQ)Greater than11.485
Debt to Asset Ratio (MRQ)Less than10.276
Debt to Equity Ratio (MRQ)Less than10.381
Return on Equity (MRQ)Greater than0.150.006
Return on Assets (MRQ)Greater than0.050.004
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Hisoar Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.903
Ma 20Greater thanMa 505.799
Ma 50Greater thanMa 1005.674
Ma 100Greater thanMa 2006.024
OpenGreater thanClose6.420
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-03-312023-06-302023-09-302023-12-312024-03-31
Interest Income  9,54541,61351,15848,33799,49426,512126,007-145,664-19,657



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets7,650,432
Total Liabilities2,113,989
Total Stockholder Equity5,541,570
 As reported
Total Liabilities 2,113,989
Total Stockholder Equity+ 5,541,570
Total Assets = 7,650,432

Assets

Total Assets7,650,432
Total Current Assets2,817,134
Long-term Assets4,833,298
Total Current Assets
Cash And Cash Equivalents 1,596,169
Net Receivables 477,138
Inventory 636,369
Other Current Assets 30,895
Total Current Assets  (as reported)2,817,134
Total Current Assets  (calculated)2,740,571
+/- 76,563
Long-term Assets
Property Plant Equipment 2,977,554
Goodwill 603,314
Intangible Assets 533,588
Long-term Assets  (as reported)4,833,298
Long-term Assets  (calculated)4,114,457
+/- 718,841

Liabilities & Shareholders' Equity

Total Current Liabilities1,897,042
Long-term Liabilities216,947
Total Stockholder Equity5,541,570
Total Current Liabilities
Short Long Term Debt 1,213,913
Accounts payable 552,950
Other Current Liabilities 1,318
Total Current Liabilities  (as reported)1,897,042
Total Current Liabilities  (calculated)1,768,181
+/- 128,861
Long-term Liabilities
Long term Debt 110,000
Capital Lease Obligations Min Short Term Debt10,189
Long-term Liabilities Other 2,662
Long-term Liabilities  (as reported)216,947
Long-term Liabilities  (calculated)122,850
+/- 94,097
Total Stockholder Equity
Retained Earnings 849,093
Total Stockholder Equity (as reported)5,541,570
Total Stockholder Equity (calculated)849,093
+/- 4,692,477
Other
Capital Stock1,618,715
Common Stock Shares Outstanding 1,618,715
Net Invested Capital 6,865,483
Net Working Capital 920,092
Property Plant and Equipment Gross 2,977,554



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302005-12-312004-12-312003-12-31
> Total Assets 
362,384
387,376
576,717
672,015
684,692
921,934
875,446
899,959
872,531
949,753
919,871
960,718
937,761
1,013,074
1,079,992
1,021,228
959,908
996,269
1,034,470
1,078,364
1,114,829
1,140,319
1,237,078
1,333,594
1,335,637
1,435,135
1,471,720
1,584,704
1,819,980
1,918,019
1,990,466
2,100,775
2,104,491
2,109,537
2,152,486
2,189,705
2,114,328
4,167,443
4,279,890
4,155,197
4,375,259
4,830,763
5,128,793
5,730,847
6,815,020
6,905,599
7,232,179
6,941,895
7,253,227
7,466,927
7,159,190
7,037,774
6,919,585
7,035,373
7,119,310
6,538,210
6,741,297
6,747,199
6,350,342
6,830,422
6,728,795
7,178,568
7,517,274
7,714,936
7,852,607
8,019,943
7,991,183
8,404,373
8,652,335
8,393,100
9,058,797
8,699,884
8,494,579
7,520,093
7,650,432
7,650,4327,520,0938,494,5798,699,8849,058,7978,393,1008,652,3358,404,3737,991,1838,019,9437,852,6077,714,9367,517,2747,178,5686,728,7956,830,4226,350,3426,747,1996,741,2976,538,2107,119,3107,035,3736,919,5857,037,7747,159,1907,466,9277,253,2276,941,8957,232,1796,905,5996,815,0205,730,8475,128,7934,830,7634,375,2594,155,1974,279,8904,167,4432,114,3282,189,7052,152,4862,109,5372,104,4912,100,7751,990,4661,918,0191,819,9801,584,7041,471,7201,435,1351,335,6371,333,5941,237,0781,140,3191,114,8291,078,3641,034,470996,269959,9081,021,2281,079,9921,013,074937,761960,718919,871949,753872,531899,959875,446921,934684,692672,015576,717387,376362,384
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,014,095
3,822,534
3,733,595
3,789,241
3,129,275
3,231,755
3,062,430
2,725,400
3,164,247
2,979,115
3,239,862
3,548,259
3,624,747
3,538,083
3,436,923
3,451,324
3,352,777
3,245,690
3,245,690
4,027,777
3,676,868
3,475,693
2,625,735
2,817,134
2,817,1342,625,7353,475,6933,676,8684,027,7773,245,6903,245,6903,352,7773,451,3243,436,9233,538,0833,624,7473,548,2593,239,8622,979,1153,164,2472,725,4003,062,4303,231,7553,129,2753,789,2413,733,5953,822,5344,014,095000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,193,260
1,555,777
1,956,089
2,008,227
1,414,207
1,576,627
1,556,575
1,253,659
1,589,769
1,566,221
1,969,699
2,179,047
2,208,134
2,037,893
1,827,930
1,705,169
1,568,907
1,769,592
1,490,816
2,305,531
1,969,378
1,925,140
1,420,571
1,596,169
1,596,1691,420,5711,925,1401,969,3782,305,5311,490,8161,769,5921,568,9071,705,1691,827,9302,037,8932,208,1342,179,0471,969,6991,566,2211,589,7691,253,6591,556,5751,576,6271,414,2072,008,2271,956,0891,555,7772,193,260000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
154,000
0
150,000
0
0
0
0
0
0
0
0
0
13,680
13,213
9,481
3,663
990
0
0
0
0
0
0
0
00000009903,6639,48113,21313,680000000000150,0000154,000000000000000000000000000000000000000000000000000000
       Net Receivables 
118,409
74,867
111,090
124,450
132,439
98,553
155,913
206,452
175,547
185,754
189,518
231,022
178,047
182,387
183,296
177,547
187,756
220,903
218,728
210,563
210,515
209,618
248,826
248,633
241,903
216,089
255,076
207,769
194,325
208,618
245,094
257,361
204,327
252,892
243,884
254,271
240,550
348,243
421,044
464,409
458,382
418,372
527,884
546,661
592,297
554,433
646,664
633,991
535,343
610,284
631,793
729,184
630,251
597,874
565,963
568,367
539,136
552,611
532,621
538,202
490,342
457,038
568,011
515,026
436,569
577,543
693,126
692,874
584,281
584,281
584,358
560,551
469,466
424,703
477,138
477,138424,703469,466560,551584,358584,281584,281692,874693,126577,543436,569515,026568,011457,038490,342538,202532,621552,611539,136568,367565,963597,874630,251729,184631,793610,284535,343633,991646,664554,433592,297546,661527,884418,372458,382464,409421,044348,243240,550254,271243,884252,892204,327257,361245,094208,618194,325207,769255,076216,089241,903248,633248,826209,618210,515210,563218,728220,903187,756177,547183,296182,387178,047231,022189,518185,754175,547206,452155,91398,553132,439124,450111,09074,867118,409
       Other Current Assets 
15,559
21,219
44,178
8,268
35,791
18,553
1,985
5,427
32,763
30,677
33,738
33,986
9,856
7,454
7,363
8,377
10,368
11,553
12,079
16,243
12,727
53,817
96,846
96,914
105,140
163,345
156,973
191,516
220,690
157,623
165,402
179,460
177,510
176,183
190,872
173,656
173,468
53,700
90,193
98,285
100,664
61,358
78,479
94,033
101,406
43,372
53,966
70,022
674,306
87,985
112,722
104,667
781,117
124,214
118,868
64,595
54,795
110,258
118,576
137,428
102,433
85,710
106,491
125,185
145,770
114,001
129,508
85,045
68,152
68,152
76,774
81,399
84,545
25,166
30,895
30,89525,16684,54581,39976,77468,15268,15285,045129,508114,001145,770125,185106,49185,710102,433137,428118,576110,25854,79564,595118,868124,214781,117104,667112,72287,985674,30670,02253,96643,372101,40694,03378,47961,358100,66498,28590,19353,700173,468173,656190,872176,183177,510179,460165,402157,623220,690191,516156,973163,345105,14096,91496,84653,81712,72716,24312,07911,55310,3688,3777,3637,4549,85633,98633,73830,67732,7635,4271,98518,55335,7918,26844,17821,21915,559
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,330,069
3,408,935
3,509,542
3,684,769
3,624,942
3,666,175
3,749,680
3,938,707
3,969,015
4,090,188
4,314,524
4,583,020
4,539,859
5,051,597
5,120,635
5,147,409
5,031,021
5,023,016
5,018,886
4,894,358
4,833,298
4,833,2984,894,3585,018,8865,023,0165,031,0215,147,4095,120,6355,051,5974,539,8594,583,0204,314,5244,090,1883,969,0153,938,7073,749,6803,666,1753,624,9423,684,7693,509,5423,408,9353,330,069000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
118,344
134,513
179,498
216,154
245,606
318,931
298,015
331,772
301,123
351,425
317,106
379,414
355,806
422,005
373,738
418,900
372,378
420,978
382,343
449,207
416,598
478,603
439,691
512,120
480,414
565,304
547,929
662,716
748,916
970,471
974,037
1,085,290
1,083,508
1,164,047
1,089,675
1,072,566
1,073,140
1,474,086
1,478,555
1,487,503
1,496,227
1,537,575
1,529,664
1,523,906
1,558,380
1,310,353
1,318,503
1,383,387
1,425,350
1,475,521
1,517,234
1,588,779
1,668,091
1,889,454
1,927,399
2,021,088
2,116,776
2,285,082
2,234,552
2,288,510
2,380,056
2,561,568
2,595,042
2,628,423
2,752,436
2,981,208
2,950,511
3,015,102
3,020,515
3,097,547
3,035,049
3,029,887
3,011,215
3,029,311
2,977,554
2,977,5543,029,3113,011,2153,029,8873,035,0493,097,5473,020,5153,015,1022,950,5112,981,2082,752,4362,628,4232,595,0422,561,5682,380,0562,288,5102,234,5522,285,0822,116,7762,021,0881,927,3991,889,4541,668,0911,588,7791,517,2341,475,5211,425,3501,383,3871,318,5031,310,3531,558,3801,523,9061,529,6641,537,5751,496,2271,487,5031,478,5551,474,0861,073,1401,072,5661,089,6751,164,0471,083,5081,085,290974,037970,471748,916662,716547,929565,304480,414512,120439,691478,603416,598449,207382,343420,978372,378418,900373,738422,005355,806379,414317,106351,425301,123331,772298,015318,931245,606216,154179,498134,513118,344
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
757,737
711,006
711,006
711,006
711,006
603,314
603,314
603,314603,314711,006711,006711,006711,006757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,737757,7370000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,307
75,195
67,888
66,257
59,153
56,592
67,879
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000067,87956,59259,15366,25767,88875,19576,307000000000000000000000000000000000000000000000000000
       Intangible Assets 
4,946
3,877
0
20,085
0
19,882
19,830
20,254
29,207
50,312
50,138
49,763
49,490
49,218
48,946
48,674
48,350
48,073
47,797
47,521
47,245
46,968
46,692
247
46,710
11,536
61,838
15,359
98,349
20,448
107,919
20,184
101,429
0
71,852
70,152
68,492
1,223,377
1,175,364
1,228,501
1,169,239
1,259,910
1,202,296
1,246,305
1,215,622
1,241,675
1,186,453
1,230,026
1,173,915
1,333,497
1,325,870
560,297
552,567
539,515
532,789
80,936
534,949
533,455
525,964
518,254
510,704
517,876
509,151
501,594
493,930
490,128
483,753
476,897
492,622
555,762
547,587
539,032
529,518
520,796
533,588
533,588520,796529,518539,032547,587555,762492,622476,897483,753490,128493,930501,594509,151517,876510,704518,254525,964533,455534,94980,936532,789539,515552,567560,2971,325,8701,333,4971,173,9151,230,0261,186,4531,241,6751,215,6221,246,3051,202,2961,259,9101,169,2391,228,5011,175,3641,223,37768,49270,15271,8520101,42920,184107,91920,44898,34915,35961,83811,53646,71024746,69246,96847,24547,52147,79748,07348,35048,67448,94649,21849,49049,76350,13850,31229,20720,25419,83019,882020,08503,8774,946
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
516
516
782
450
450
0
2,380,056
0
0
0
0
30,881
30,000
0
46,100
0
0
0
0
16,970
0
016,970000046,100030,00030,88100002,380,0560450450782516516000000000000000000000000000000000000000000000000000000
> Total Liabilities 
277,357
255,348
393,757
469,372
468,848
402,664
341,721
371,026
333,880
411,694
369,866
413,505
388,171
465,576
528,521
475,907
408,945
434,482
454,840
485,644
492,070
502,281
565,801
664,017
632,970
698,174
691,794
824,300
1,031,959
1,179,972
1,250,683
1,363,633
1,395,249
1,476,738
1,518,903
1,537,557
1,463,863
988,734
782,070
785,302
877,093
1,258,017
1,527,893
1,950,534
1,881,380
2,135,260
2,333,963
1,907,637
2,167,650
2,324,919
1,961,652
1,790,262
1,509,640
1,644,823
2,005,548
1,087,452
1,096,240
1,022,737
987,270
1,306,914
1,108,973
1,326,499
1,551,864
1,722,628
1,788,825
1,906,321
1,772,229
2,244,006
2,438,355
2,288,185
2,912,034
2,657,509
2,510,122
1,918,372
2,113,989
2,113,9891,918,3722,510,1222,657,5092,912,0342,288,1852,438,3552,244,0061,772,2291,906,3211,788,8251,722,6281,551,8641,326,4991,108,9731,306,914987,2701,022,7371,096,2401,087,4522,005,5481,644,8231,509,6401,790,2621,961,6522,324,9192,167,6501,907,6372,333,9632,135,2601,881,3801,950,5341,527,8931,258,017877,093785,302782,070988,7341,463,8631,537,5571,518,9031,476,7381,395,2491,363,6331,250,6831,179,9721,031,959824,300691,794698,174632,970664,017565,801502,281492,070485,644454,840434,482408,945475,907528,521465,576388,171413,505369,866411,694333,880371,026341,721402,664468,848469,372393,757255,348277,357
   > Total Current Liabilities 
205,632
217,348
386,190
384,145
383,585
400,260
339,294
371,027
333,880
411,694
369,866
413,314
388,171
465,554
528,522
475,907
378,897
403,802
423,425
435,168
423,832
424,181
487,701
550,917
499,870
537,938
511,361
626,300
858,345
682,615
722,940
859,967
868,979
977,071
982,650
1,034,137
986,862
866,421
662,739
620,096
715,258
1,041,074
1,353,491
1,559,263
1,493,874
1,753,955
2,149,237
1,775,848
2,034,497
2,184,758
1,822,803
1,708,828
1,419,634
1,579,026
1,947,519
1,034,840
1,035,290
940,282
906,769
1,179,042
982,537
1,181,754
1,388,791
1,567,177
1,631,809
1,732,690
1,600,549
2,077,103
1,970,677
1,970,677
2,729,426
2,469,315
2,322,788
1,806,828
1,897,042
1,897,0421,806,8282,322,7882,469,3152,729,4261,970,6771,970,6772,077,1031,600,5491,732,6901,631,8091,567,1771,388,7911,181,754982,5371,179,042906,769940,2821,035,2901,034,8401,947,5191,579,0261,419,6341,708,8281,822,8032,184,7582,034,4971,775,8482,149,2371,753,9551,493,8741,559,2631,353,4911,041,074715,258620,096662,739866,421986,8621,034,137982,650977,071868,979859,967722,940682,615858,345626,300511,361537,938499,870550,917487,701424,181423,832435,168423,425403,802378,897475,907528,522465,554388,171413,314369,866411,694333,880371,027339,294400,260383,585384,145386,190217,348205,632
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
515,700
241,700
326,700
200,267
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000200,267326,700241,700515,700000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
515,700
241,700
326,700
200,267
210,272
410,290
240,253
430,438
630,469
779,407
660,428
570,583
570,590
1,047,811
1,236,182
832,461
1,521,968
1,416,754
1,335,480
1,028,833
1,213,913
1,213,9131,028,8331,335,4801,416,7541,521,968832,4611,236,1821,047,811570,590570,583660,428779,407630,469430,438240,253410,290210,272200,267326,700241,700515,700000000000000000000000000000000000000000000000000000000
       Accounts payable 
58,289
42,709
137,220
133,531
119,215
124,737
121,659
144,955
147,036
174,209
130,853
175,789
180,916
211,045
266,039
230,675
155,938
176,291
218,887
228,683
206,410
225,090
270,747
299,136
243,109
241,514
243,331
265,227
349,031
378,492
339,846
359,815
333,716
396,740
355,392
373,316
369,914
401,443
281,168
233,766
208,458
214,065
278,701
221,860
242,729
372,584
487,750
524,402
636,110
733,156
696,189
595,998
594,372
791,915
794,889
647,477
551,730
601,747
567,070
663,137
627,720
613,250
601,530
692,956
868,504
1,028,759
884,370
904,263
995,041
995,041
1,070,229
866,919
819,157
603,339
552,950
552,950603,339819,157866,9191,070,229995,041995,041904,263884,3701,028,759868,504692,956601,530613,250627,720663,137567,070601,747551,730647,477794,889791,915594,372595,998696,189733,156636,110524,402487,750372,584242,729221,860278,701214,065208,458233,766281,168401,443369,914373,316355,392396,740333,716359,815339,846378,492349,031265,227243,331241,514243,109299,136270,747225,090206,410228,683218,887176,291155,938230,675266,039211,045180,916175,789130,853174,209147,036144,955121,659124,737119,215133,531137,22042,70958,289
       Other Current Liabilities 
35,793
26,282
22,750
33,323
23,830
26,571
16,214
12,508
1,560
6,025
5,032
11,248
1,482
0
2,627
3,891
10,534
17,200
23,072
27,153
42,215
42,070
38,376
43,366
39,834
41,398
39,563
24,610
32,783
58,182
56,734
57,546
66,957
84,194
116,995
80,270
64,117
158,601
200,894
157,647
120,037
212,970
145,790
127,164
137,145
128,976
159,111
110,955
81,387
106,115
98,614
68,564
98,696
120,528
44,366
78,272
111,547
61,698
68,602
43,446
68,872
39,829
97,478
37,717
59,193
39,940
82,950
52,168
54,269
54,269
77,129
119,427
121,274
1,183
1,318
1,3181,183121,274119,42777,12954,26954,26952,16882,95039,94059,19337,71797,47839,82968,87243,44668,60261,698111,54778,27244,366120,52898,69668,56498,614106,11581,387110,955159,111128,976137,145127,164145,790212,970120,037157,647200,894158,60164,11780,270116,99584,19466,95757,54656,73458,18232,78324,61039,56341,39839,83443,36638,37642,07042,21527,15323,07217,20010,5343,8912,62701,48211,2485,0326,0251,56012,50816,21426,57123,83033,32322,75026,28235,793
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,029
52,612
60,950
82,455
80,501
127,872
126,436
144,745
163,073
155,452
157,015
173,631
171,680
166,903
173,493
317,508
182,608
188,194
187,334
111,544
216,947
216,947111,544187,334188,194182,608317,508173,493166,903171,680173,631157,015155,452163,073144,745126,436127,87280,50182,45560,95052,61258,029000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-515,700
-241,700
-326,700
-200,267
0
0
0
0
24,492
20,590
20,103
17,822
18,091
16,473
16,360
14,014
14,036
12,169
12,169
10,210
10,189
10,18910,21012,16912,16914,03614,01416,36016,47318,09117,82220,10320,59024,4920000-200,267-326,700-241,700-515,700000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,821
1,333
1,333
1,333
1,333
1,333
1,333
2,333
1,333
1,333
1,333
1,333
1,333
1,333
1,333
1,333
1,333
1,333
1,333
2,677
2,662
2,6622,6771,3331,3331,3331,3331,3331,3331,3331,3331,3331,3331,3332,3331,3331,3331,3331,3331,3331,3336,821000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,266
1,938
1,842
1,787
1,731
1,675
1,619
1,563
1,507
1,451
1,395
1,339
1,283
1,227
2,519
2,405
2,290
2,061
2,061
2,073
1,952
2,213
0
0
002,2131,9522,0732,0612,0612,2902,4052,5191,2271,2831,3391,3951,4511,5071,5631,6191,6751,7311,7871,8421,9381,266000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
81,915
128,763
181,049
200,256
213,370
516,686
531,085
526,166
535,801
535,076
546,941
544,070
546,488
544,623
548,593
542,457
548,064
558,875
576,576
589,592
619,629
634,885
668,048
666,351
699,367
728,829
772,114
753,173
760,131
711,722
714,896
712,704
686,607
623,112
626,476
653,633
653,811
3,184,357
3,505,230
3,378,829
3,508,415
3,585,546
3,616,268
3,799,228
4,955,355
4,767,697
4,895,541
5,034,258
5,085,577
5,142,008
5,197,538
5,247,512
5,409,945
5,390,550
5,113,762
5,450,758
5,645,057
5,724,462
5,363,073
5,523,508
5,619,821
5,852,086
5,965,768
5,993,071
6,064,963
6,115,001
6,220,809
6,162,358
6,216,302
6,107,979
6,150,081
6,046,215
5,988,455
5,606,352
5,541,570
5,541,5705,606,3525,988,4556,046,2156,150,0816,107,9796,216,3026,162,3586,220,8096,115,0016,064,9635,993,0715,965,7685,852,0865,619,8215,523,5085,363,0735,724,4625,645,0575,450,7585,113,7625,390,5505,409,9455,247,5125,197,5385,142,0085,085,5775,034,2584,895,5414,767,6974,955,3553,799,2283,616,2683,585,5463,508,4153,378,8293,505,2303,184,357653,811653,633626,476623,112686,607712,704714,896711,722760,131753,173772,114728,829699,367666,351668,048634,885619,629589,592576,576558,875548,064542,457548,593544,623546,488544,070546,941535,076535,801526,166531,085516,686213,370200,256181,049128,76381,915
   Common Stock
30,000
80,000
80,000
80,000
80,000
107,000
107,000
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
160,500
161,463
161,463
161,463
322,925
324,490
324,490
324,490
324,490
324,490
324,490
324,490
324,490
324,490
723,044
757,759
757,759
757,759
759,759
1,519,517
1,522,877
1,622,767
1,622,767
1,622,767
1,621,610
1,621,610
1,621,610
1,621,610
1,618,820
1,618,820
1,618,820
1,618,820
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
1,618,715
0
0
001,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,7151,618,8201,618,8201,618,8201,618,8201,621,6101,621,6101,621,6101,621,6101,622,7671,622,7671,622,7671,522,8771,519,517759,759757,759757,759757,759723,044324,490324,490324,490324,490324,490324,490324,490324,490324,490322,925161,463161,463161,463160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500160,500107,000107,00080,00080,00080,00080,00030,000
   Retained Earnings 
39,018
31,614
73,676
92,613
105,728
110,441
124,654
119,735
129,370
128,847
140,711
137,841
140,259
136,254
140,224
134,088
139,695
147,449
168,207
178,166
205,817
208,482
238,064
232,787
254,015
278,951
320,939
299,402
297,281
250,929
254,084
253,403
227,303
168,822
208,926
212,797
213,370
259,085
419,924
439,434
558,148
624,120
605,104
776,176
906,412
697,235
813,548
892,278
934,067
991,035
1,035,803
1,105,144
1,312,311
1,434,294
968,222
1,261,597
1,455,896
1,738,398
1,376,806
1,537,281
1,633,613
1,591,401
1,648,589
1,619,533
1,635,687
1,654,256
1,741,280
1,664,046
1,580,398
1,580,398
1,622,500
1,518,634
1,460,874
816,500
849,093
849,093816,5001,460,8741,518,6341,622,5001,580,3981,580,3981,664,0461,741,2801,654,2561,635,6871,619,5331,648,5891,591,4011,633,6131,537,2811,376,8061,738,3981,455,8961,261,597968,2221,434,2941,312,3111,105,1441,035,803991,035934,067892,278813,548697,235906,412776,176605,104624,120558,148439,434419,924259,085213,370212,797208,926168,822227,303253,403254,084250,929297,281299,402320,939278,951254,015232,787238,064208,482205,817178,166168,207147,449139,695134,088140,224136,254140,259137,841140,711128,847129,370119,735124,654110,441105,72892,61373,67631,61439,018
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000-172,029-117,092-100,403-100,403-100,403-100,403-152,278-152,278-152,278-152,278-134,548-173,468-156,218-156,218000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
139
-334
-52
303
-206
-206
-1,490
-1,287
-1,327
-1,346
-1,339
-1,195
-1,187
-1,800
-1,637
-1,637
-1,637
2,586
2,586
2,586
2,586
2,586
0
0
002,5862,5862,5862,5862,586-1,637-1,637-1,637-1,800-1,187-1,195-1,339-1,346-1,327-1,287-1,490-206-206303-52-334139000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,171,887
Cost of Revenue-1,867,244
Gross Profit304,642304,642
 
Operating Income (+$)
Gross Profit304,642
Operating Expense-2,338,252
Operating Income-166,365-2,033,609
 
Operating Expense (+$)
Research Development115,565
Selling General Administrative130,581
Selling And Marketing Expenses0
Operating Expense2,338,252246,146
 
Net Interest Income (+$)
Interest Income68,125
Interest Expense-37,763
Other Finance Cost-1,853
Net Interest Income28,509
 
Pretax Income (+$)
Operating Income-166,365
Net Interest Income28,509
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-466,223-166,365
EBIT - interestExpense = -37,763
-420,056
-382,293
Interest Expense37,763
Earnings Before Interest and Taxes (EBIT)0-428,460
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-466,223
Tax Provision--44,642
Net Income From Continuing Ops-421,581-421,581
Net Income-420,056
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-28,509
 

Technical Analysis of Hisoar
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hisoar. The general trend of Hisoar is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hisoar's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Hisoar Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 6.5 < 6.62 < 6.6498.

The bearish price targets are: 6.29 > 5.05 > 3.91.

Tweet this
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Hisoar Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current macd is 0.13932848.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hisoar price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Hisoar. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Hisoar price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current adx is 16.39.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Hisoar shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Hisoar Pharmaceutical Co Ltd. The current sar is 5.35892977.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current rsi is 66.90. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Hisoar Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hisoar price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current cci is 158.08.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current cmo is 47.26.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Hisoar Pharmaceutical Co Ltd. The current willr is -2.11267606.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Hisoar Pharmaceutical Co Ltd.

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current atr is 0.23435651.

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current obv is 469,116,752.

Zhejiang Hisoar Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Hisoar Pharmaceutical Co Ltd. The current mfi is 64.83.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Hisoar Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Hisoar Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Hisoar Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Zhejiang Hisoar Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Hisoar Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.903
Ma 20Greater thanMa 505.799
Ma 50Greater thanMa 1005.674
Ma 100Greater thanMa 2006.024
OpenGreater thanClose6.420
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hisoar with someone you think should read this too:
  • Are you bullish or bearish on Hisoar? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hisoar? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Hisoar Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Hisoar Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Hisoar Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Hisoar Pharmaceutical Co Ltd in your mailbox!